Efficacy of clarithromycin as a protective agent in the methotrexate-induced pulmonary fibrosis model.
Conclusions: Clarithromycin was shown to be effective in protecting against methotrexate-induced pulmonary fibrosis; further studies should be performed to determine the dosage and safety.
PMID: 30647742 [PubMed]
Source: Polish Journal of Cardio-Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Tags: Kardiochir Torakochirurgia Pol Source Type: research
More News: Ankylosing Spondylitis | Arthritis | Biaxin | Cancer | Cancer & Oncology | Cardiology | Cardiovascular & Thoracic Surgery | Clarithromycin | Heart | Leukemia | Methotrexate | Oral Cancer | Poland Health | Psoriasis | Rheumatoid Arthritis | Rheumatology | Study | Toxicology